Cannagistics Inc. (OTCPK:CNGT) signed a definitive agreement to acquire Cannaworx, Inc. from Availa Bio, Inc. on July 1, 2021. Under the terms of the agreement, Cannagistics will issue to Availa 4,400,000 shares of CNGT Convertible Preferred ?F? stock. The transaction is subject to the regulatory approvals, and other customary closing conditions. Cannagistics Inc. (OTCPK:CNGT) completed the acquisition of Cannaworx, Inc. from Availa Bio, Inc. on July 1, 2021. As of November 5, 2021, Cannagistics, Inc. announces that they have applied for the name change and symbol change, in accordance with the rules of SEC and FINRA. Rob Gietl will remain as President and as a Director of the Company. Joining the Board of Directors of the Company will be Jim Morrison, as Chairman of the Board of Directors, and Babak "Bobby" Ghalili, as a Director and Chief Science Officer of the Company. James W Zimbler, as part of the transition and appointment of new members of the Board, will resign from the Board of Directors and remain as Vice-President of Operations/Compliance of the company. The Company is working to apply for a listing on OTCQB.